title: Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB.
abstract: The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5]. To identify proteins associated with the TNF signaling pathway, we performed a yeast two-hybrid interaction screen using RIP as bait. We isolated a kinase, RIP3, which shares homology with the kinase domain of RIP and RIP2 (also known as Rick or CARDIAK). RIP3 could be co-immunoprecipitated with RIP, TRAF2 and TNFR1 in mammalian cells. The carboxy-terminal domain of RIP3, like that of RIP, could activate the transcription factor NFkappaB and induce apoptosis when expressed in mammalian cells. Interestingly, this region shares no significant sequence homology to the death domain of RIP, the caspase-recruiting domain (CARD) of RIP2 [6][7][8] or any other apoptosis-inducing domain. As with RIP and RIP2, the kinase domain of RIP3 was not required for either NFkappaB activation or apoptosis induction. Overexpression of a dominant-negative mutant of RIP3 strongly inhibited the caspase activation but not the NFkappaB activation induced by TNFalpha. Therefore, RIP3 appears to function as an intermediary in TNFalpha-induced apoptosis.
authors.affiliation: Rigel, Inc. 240 East Grand Ave, South San Francisco, California 94080, USA.
authors.forename: P W
authors.initials: PW
authors.lastname: Yu
authors.forename: B C
authors.initials: BC
authors.lastname: Huang
authors.forename: M
authors.initials: M
authors.lastname: Shen
authors.forename: J
authors.initials: J
authors.lastname: Quast
authors.forename: E
authors.initials: E
authors.lastname: Chan
authors.forename: X
authors.initials: X
authors.lastname: Xu
authors.forename: G P
authors.initials: GP
authors.lastname: Nolan
authors.forename: D G
authors.initials: DG
authors.lastname: Payan
authors.forename: Y
authors.initials: Y
authors.lastname: Luo
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D002460:Cell Line; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins / Q000494:pharmacology; D016328:NF-kappa B / Q000378:metabolism*; D011485:Protein Binding; D011494:Protein Kinases / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism; D047992:TNF Receptor-Associated Factor 2; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D011506:Proteins; D047992:TNF Receptor-Associated Factor 2; D014409:Tumor Necrosis Factor-alpha; D011494:Protein Kinases